Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
RedHill Biopharma wins Nasdaq extension to regain $1 minimum bid compliance by April 5, 2027

RedHill Biopharma wins Nasdaq extension to regain $1 minimum bid compliance by April 5, 2027

BitgetBitget2026/10/07 12:02

RedHill Biopharma won a Nasdaq extension to regain compliance with the $1.00 minimum bid price rule. New deadline set for April 5, 2027, following an initial compliance period that ended Oct. 5, 2026. Nasdaq will close the matter if the ADS bid price holds at or above $1.00 for 10 consecutive business days. Notice does not immediately affect the ADS listing or trading on Nasdaq Capital Market under RDHL. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redhill Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004732), on October 07, 2026, and is solely responsible for the information contained therein.

  • RedHill Biopharma won a Nasdaq extension to regain compliance with the $1.00 minimum bid price rule.
  • New deadline set for April 5, 2027, following an initial compliance period that ended Oct. 5, 2026.
  • Nasdaq will close the matter if the ADS bid price holds at or above $1.00 for 10 consecutive business days.
  • Notice does not immediately affect the ADS listing or trading on Nasdaq Capital Market under RDHL.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redhill Biopharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004732), on October 07, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging

According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.

智通财经•2026/11/09 08:47
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging

Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Japan's spot electricity prices surged to multi-year highs over the weekend.

智通财经•2026/11/09 08:07
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail

Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

智通财经•2026/11/09 07:32
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail